Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer (BC).

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Khasraw, M; Mukaro, VR; West, L; Brandt, C; Woollett, AM; Edwards, M; Spokes, R; Mitchell, G; Prince, K; Hayes, TM; Collins, IM; Guminski, AD; Baron-Hay, SE; Olesen, IH; Bryan, J; Bowles, S; Wong, SF; Ashley, DM; Patil, S

Published Date

  • May 20, 2015

Published In

Volume / Issue

  • 33 / 15

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer

Conference Location

  • Chicago, IL

Conference Start Date

  • May 29, 2015

Conference End Date

  • June 2, 2015